Assessing Prescribing Patterns of Nonstatins as Add-on Therapy for Secondary Prevention in a Federally Qualified Health Center.

In this study, although the association between having a clinical pharmacist appointment and being prescribed ezetimibe did not reach statistical significance ( p = 0.05), it did suggest that individuals engaging with a clinical pharmacist were more likely to be receiving ezetimibe as add-on therapy to statins.

also in 111,027 other papers

While not statistically significant, there was a trend towards significance for the relationship between receiving a prescription for ezetimibe and having an appointment with a clinical pharmacist ( p = 0.05). 4.

also in 2,760 other papers